MedPath
HSA Approval

ATROPINE SULPHATE INJECTION 0.6 mg/ml

SIN03441P

ATROPINE SULPHATE INJECTION 0.6 mg/ml

ATROPINE SULPHATE INJECTION 0.6 mg/ml

June 16, 1989

ATLANTIC PHARMACEUTICAL (S) PTE LTD

ATLANTIC PHARMACEUTICAL (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantATLANTIC PHARMACEUTICAL (S) PTE LTD
Licence HolderATLANTIC PHARMACEUTICAL (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR

Medical Information

A03BA01

atropine

Manufacturer Information

atlantic pharmaceutical (s) pte ltd

ATLANTIC LABORATORIES CORPN LTD

Active Ingredients

ATROPINE SULPHATE

0.6 mg/ml

Atropine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ATROPINE SULPHATE INJECTION 0.6 mg/ml - HSA Approval | MedPath